Sanofi Ventures

Sanofi Ventures Sanofi Ventures is the CVC arm of Sanofi, a top-5 global pharmaceutical company. The fund now exceeds $1.4B in AUM after a $625M addition in September 2025. Since inception in 2012, the firm has deployed $800M+ across 70+ innovative biotech and digital health companies. Focus areas align with Sanofi's strategic priorities: immunology, rare diseases, neurology, and vaccines. The exit track record in 2024 was particularly strong. three exits with $3.25B in combined acquisition val